Pure Global: Singapore & Malaysia's MedTech Shortcut - The New Reliance Playbook episode artwork

EPISODE · May 5, 2026 · 1 MIN

Pure Global: Singapore & Malaysia's MedTech Shortcut - The New Reliance Playbook

from ASEAN MedTech Insights

This week, we dissect the game-changing regulatory reliance pilot program between Malaysia’s MDA and Singapore’s HSA. This collaboration is creating a powerful new shortcut for MedTech market access in ASEAN, allowing companies to leverage a single approval process to enter two key markets faster than ever before. We explore the practical details of the new Verification and Abridged review pathways, revealing how they can reduce approval timelines by up to 30%. For any MedTech firm looking to expand, this episode offers a crucial look into the future of a more harmonized and accessible ASEAN regulatory landscape. **Case Study Teaser:** Imagine your Class C device just received approval in Singapore. Previously, your team would budget for another 9-12 month review cycle for Malaysia. Now, by leveraging the new reliance pathway, you could potentially be on the Malaysian market in a fraction of that time, beating your competitors and generating revenue months ahead of schedule. **本期干货 (Key Takeaways):** * What are the exact eligibility criteria for a device to qualify for the MDA-HSA reliance program? * How does the documentation for a "Verification Route" differ from a full standard submission? * Are there any hidden pitfalls or device classifications that are excluded from this pilot? * Could a CE Mark or US FDA approval be used in conjunction with this program for even faster review? * How should this new pathway change a startup's entire ASEAN market entry strategy? * Is this reliance model expected to expand to other ASEAN countries like Thailand or Vietnam soon? * What are the specific risks if your initial HSA or MDA approval has conditions or limitations? At Pure Global, we specialize in turning these regulatory shifts into your competitive advantage. Our local experts in Singapore and Malaysia can manage the entire submission process, ensuring your dossier perfectly aligns with the new reliance pathway requirements. From initial strategy to post-market surveillance, we make multi-market access a single, streamlined process. To accelerate your ASEAN expansion, contact us at [email protected] or visit https://pureglobal.com/.

Episode metadata supplied by the publisher feed · Published May 5, 2026

Embed this episode

NOW PLAYING

Pure Global: Singapore & Malaysia's MedTech Shortcut - The New Reliance Playbook

0:00 1:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ASEAN MedTech Insights?

This episode is 1 minute long.

When was this ASEAN MedTech Insights episode published?

This episode was published on May 5, 2026.

Can I download this ASEAN MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!